Research Administration > OHRPP > UCLA Clinical Translational Science Institute IRB Group
Skip navigation links
Home
Contact OHRPPExpand Contact OHRPP
For ResearchersExpand For Researchers
Consent TemplatesExpand Consent Templates
IRB RelianceExpand IRB Reliance
Policies and GuidanceExpand Policies and Guidance
Education and TrainingExpand Education and Training
Post Approval Reporting
Quality ImprovementExpand Quality Improvement
For and About the IRBExpand For and About the IRB
For Research ParticipantsExpand For Research Participants
Other ResourcesExpand Other Resources
About the OHRPPExpand About the OHRPP
webIRB Home
HIPAA FAQs

UCLA Clinical Translational Science Institute IRB Group
 
This MOU represents a reciprocal IRB agreement and, therefore, allows an IRB at any one of the institutions below to rely on one of the other institution’s IRB for review and approval of human subjects research for collaborative research, under certain specified conditions: 

  • Burns and Allen Research Institute at Cedars-Sinai Medical Center (Cedars-Sinai),
  • Charles R. Drew University of Medicine and Science (CDU),
  • Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed),
  • UCLA, and
  • University of Southern California (USC) (added in Spring 2015)


Additional information is available at the following links:

 

For more information, please contact irbreliance@research.ucla.edu.

 

 

 

Page Last Updated: April 27, 2018